|Other names||Lu AA24530; Lu-AA-24530|
|Chemical and physical data|
|Molar mass||283.43 g/mol g·mol−1|
|3D model (JSmol)|
|NY (what is this?)|
Tedatioxetine (Lu AA24530) is an antidepressant that was discovered by scientists at Lundbeck; in 2007 Lundbeck and Takeda entered into a partnership that included tedatioxetine but was focused on another, more advanced Lundbeck drug candidate, vortioxetine.
As of 2009, it was in phase II clinical trials for major depressive disorder, but there have been no updates since then, and as of August 2013 it was no longer displayed on Lundbeck's product pipeline.
On May 10, 2016, all work on tedatioxetine stopped.
A Sino Patent manages to show that there has been interest in this compound outside of Lundbeck: WO 2015090160
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|